U.S. health authorities, the CDC and the FDA, recommended Tuesday that vaccination with Janssen’s serum be halted in the country while half a dozen vascular accidents are being investigated for possible links to the Johnson & Johnson drug.

The European Medicines Agency (EMA) has also been investigating since Friday the risk of developing thromboembolism with Janssen’s Covid-19 vaccine after receiving a “safety alert” related to several serious cases of blood clotting after vaccination with this preparation.

As confirmed by the EMA, and following the meetings held by its safety committee (PRAC) from last Tuesday to this Friday, its experts have initiated a “review” of cases to investigate thromboembolic events or the formation of blood clots in people vaccinated with Janssen.

LEAVE A REPLY

Please enter your comment!
Please enter your name here